Jurgen Barth

Academic / Other · 2 registered clinical trials.

Status	Trial	Phase	Started
Active Not Recruiting	Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas Follicular Lymphomas, Immunocytomas, Marginal Zone Lymphomas	Phase 3	2009-04-01
Completed	Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab Hairy Cell Leukemia (HCL)	Phase 2	2004-06-01